首页> 外文期刊>Anaesthesia and intensive care >Gastrointestinal perfusion in septic shock.
【24h】

Gastrointestinal perfusion in septic shock.

机译:败血性休克的胃肠道灌注。

获取原文
获取原文并翻译 | 示例
       

摘要

Septic shock is characterised by vasodilation, myocardial depression and impaired microcirculatory blood flow, resulting in redistribution of regional blood flow. Animal and human studies have shown that gastrointestinal mucosal blood flow is impaired in septic shock. This is consistent with abnormalities found in many other microcirculatory vascular beds. Gastrointestinal mucosal microcirculatory perfusion deficits have been associated with gut injury and a decrease in gut barrier function, possibly causing augmentation of systemic inflammation and distant organ dysfunction. A range of techniques have been developed and used to quantify these gastrointestinal perfusion abnormalities. The following techniques have been used to study gastrointestinal perfusion in humans: tonometry, laser Doppler flowmetry, reflectance spectrophotometry, near-infrared spectroscopy, orthogonal polarisation spectral imaging, indocyanine green clearance, hepatic vein catheterisation and measurements of plasma D-lactate. Although these methods share the ability to predict outcome in septic shock patients, it is important to emphasise that the measurement results are not interchangeable. Different techniques measure different elements of gastrointestinal perfusion. Gastric tonometry is currently the most widely used technique because of its non-invasiveness and ease of use. Despite all the recent advances, the usefulness of gastrointestinal perfusion parameters in clinical decision-making is still limited. Treatment strategies specifically aimed at improving gastrointestinal perfuision have failed to actually correct mucosal perfusion abnormalities and hence not shown to improve important clinical endpoints. Current and future treatment strategies for septic shock should be tested for their effects on gastrointestinal perfusion; to further clarify its exact role in patient management, and to prevent therapies detrimental to gastrointestinal perfusion being implemented.
机译:败血性休克的特征是血管扩张,心肌抑制和微循环血流受损,导致局部血流重新分布。动物和人体研究表明,败血性休克会损害肠胃黏膜的血流。这与在许多其他微循环血管床中发现的异常一致。胃肠道粘膜微循环灌注不足与肠损伤和肠屏障功能降低有关,可能导致全身性炎症增加和远处器官功能障碍。已经开发了一系列技术,并用于量化这些胃肠道灌注异常。以下技术已用于研究人体的胃肠道灌注:眼压测定,激光多普勒血流测定,反射分光光度法,近红外光谱,正交偏振光谱成像,吲哚菁绿清除率,肝静脉导管插入术和血浆D-乳酸的测量。尽管这些方法具有预测败血性休克患者预后的能力,但重要的是要强调测量结果不可互换。不同的技术会测量胃肠道灌注的不同元素。胃压计由于其无创性和易用性,是目前使用最广泛的技术。尽管最近取得了所有进展,但胃肠道灌注参数在临床决策中的实用性仍然有限。专门针对改善胃肠道灌注的治疗策略未能真正纠正粘膜灌注异常,因此未显示可改善重要的临床终点。应对脓毒性休克的当前和未来治疗策略对胃肠道灌注的影响进行测试;进一步阐明其在患者管理中的确切作用,并防止实施对胃肠灌注有害的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号